X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Pharma Packaging Market In Europe To Hit $35bn Come 2028

Content Team by Content Team
3rd November 2023
in News, Packaging & Logistic
Pharma Packaging Market In Europe To Hit $35bn Come 2028

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

As per a report furnished by Arizton, the pharma packaging and labelling market across Europe is expected to reach $35.78 billion by 2028.

This particular segment in Europe, which was valued at $27.04 billion in 2022, is projected to grow at a CAGR of 4.78% until 2028.

Europe maintains an important spot in the worldwide pharmaceutical packaging and labelling market

The authors emphasised that Europe led the global market, accounting for 27% in 2022. There are several factors that contribute to the growth of the pharmaceutical industry, which include an increased demand for prescription drugs, advances in label design and printing, significant investments in pharmaceutical sales, high R&D spending on pharmaceuticals, as well as government initiatives.

According to the market report on Europe’s pharmaceutical packaging market, the category of pharmaceutical companies comprised the highest share of 45.99% in 2022, based on end-user segmentation. The projected growth rate for this is expected to be the highest among all other rates, with a CAGR of 5.27% during the forecast period from 2023 to 2028. As per the authors, the driving factors include a growing need for branded drugs, over-the-counter medicines, as well as specialty medicine.

Packaging materials 

According to the report authors, the initial packaging segment held the highest share of 70.40% within the packaging segment of the pharmaceutical market in 2022. They emphasised that primary packaging happens to be an integral part of the pharmaceutical product. It is projected that this will experience the highest CAGR of 5.01% during the forecast period of 2023–2028. The medicine packaging as well as labelling market in Europe is being influenced by the increasing demand for various types of medicine packaging, including blisters, bottles, vials, sachets, ampoules, pouches, as well as bags.

According to the report, paper accounted for the largest share of 39.76% in 2022 in terms of material type. The forecast for this share indicates a projected CAGR of 4.80%. The rising demand in the pharmaceutical packaging market can be attributed to sustainability, particularly the use of recyclable materials.

Previous Post

Prominent Pharma Antitrust Lawsuits Over The Last Decade

Next Post

Improving Approach of UK Through Future Clinical Trials Bill

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Next Post

Improving Approach of UK Through Future Clinical Trials Bill

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In